CancerVax has developed a vaccine comprised of three irradiated melanoma cell lines that appear to be highly immunogenic and appear to cause an immune response in most patients with melanoma.
5931 Darwin Court
Carlsbad, CA 92008
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Psychedelics appear to be in vogue after years of being relegated to alternative medicine. But investor pushback after the highly anticipated release of Phase III trial data by Compass Pathways reveals an increasingly high bar for development.
Emerging Company Profile: Early-stage biotech Eolo will seek cash and deals for its novel obesity drug SANA after positive Phase I results for weight loss, lean muscle mass preservation and fat mass reduction.
Roctavian shows durable bleed control and safety over five years, but high costs and access hurdles limit its commercial outlook.
